Kornitzer Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.8M Sell
108,463
-2,677
-2% -$2.71M 2.15% 5
2025
Q4
$119M Sell
111,140
-12,388
-10% -$11.8M 2.48% 3
2025
Q3
$94.3M Buy
123,528
+2,928
+2% +$2.18M 1.89% 4
2025
Q2
$94M Sell
120,600
-995
-0.8% -$773K 1.89% 3
2025
Q1
$100M Sell
121,595
-5,958
-5% -$4.96M 2.07% 3
2024
Q4
$98.5M Sell
127,553
-2,387
-2% -$1.98M 1.92% 4
2024
Q3
$115M Sell
129,940
-2,260
-2% -$2.03M 2.13% 3
2024
Q2
$120M Sell
132,200
-5,197
-4% -$4.16M 2.27% 2
2024
Q1
$107M Sell
137,397
-10,570
-7% -$7.52M 1.96% 2
2023
Q4
$86.3M Sell
147,967
-5,187
-3% -$3.03M 1.68% 4
2023
Q3
$82.3M Sell
153,154
-1,384
-0.9% -$713K 1.7% 5
2023
Q2
$72.5M Sell
154,538
-6,629
-4% -$2.78M 1.42% 6
2023
Q1
$55.3M Sell
161,167
-3,080
-2% -$1.04M 1.1% 13
2022
Q4
$60.1M Sell
164,247
-1,540
-0.9% -$546K 1.22% 11
2022
Q3
$53.6M Sell
165,787
-3,030
-2% -$960K 1.15% 13
2022
Q2
$54.7M Sell
168,817
-11,960
-7% -$3.59M 1.09% 13
2022
Q1
$51.8M Sell
180,777
-2,619
-1% -$674K 0.85% 17
2021
Q4
$50.7M Sell
183,396
-5,057
-3% -$1.28M 0.76% 19
2021
Q3
$43.5M Sell
188,453
-1,535
-0.8% -$379K 0.67% 19
2021
Q2
$43.6M Sell
189,988
-11,005
-5% -$2.21M 0.66% 27
2021
Q1
$37.5M Sell
200,993
-5,842
-3% -$1.14M 0.6% 37
2020
Q4
$34.9M Sell
206,835
-1,197
-0.6% -$179K 0.59% 39
2020
Q3
$30.8M Sell
208,032
-8,835
-4% -$1.37M 0.6% 36
2020
Q2
$35.6M Sell
216,867
-28,718
-12% -$4.41M 0.72% 25
2020
Q1
$34.1M Sell
245,585
-14,615
-6% -$2.01M 0.81% 22
2019
Q4
$34.2M Sell
260,200
-9,310
-3% -$1.08M 0.6% 42
2019
Q3
$30.1M Sell
269,510
-5,230
-2% -$582K 0.55% 51
2019
Q2
$30.4M Sell
274,740
-2,270
-0.8% -$267K 0.54% 55
2019
Q1
$35.9M Sell
277,010
-2,435
-0.9% -$296K 0.65% 39
2018
Q4
$32.3M Sell
279,445
-3,190
-1% -$356K 0.65% 38
2018
Q3
$30.3M Sell
282,635
-2,540
-0.9% -$254K 0.48% 78
2018
Q2
$24.3M Sell
285,175
-1,772
-0.6% -$146K 0.41% 91
2018
Q1
$22.2M Sell
286,947
-435
-0.2% -$35K 0.38% 102
2017
Q4
$24.3M Sell
287,382
-8,705
-3% -$741K 0.41% 83
2017
Q3
$25.3M Sell
296,087
-1,955
-0.7% -$160K 0.44% 74
2017
Q2
$24.5M Sell
298,042
-7,575
-2% -$618K 0.43% 73
2017
Q1
$25.7M Sell
305,617
-1,783
-0.6% -$143K 0.46% 64
2016
Q4
$22.6M Sell
307,400
-5,350
-2% -$398K 0.42% 74
2016
Q3
$25.1M Sell
312,750
-4,900
-2% -$392K 0.45% 72
2016
Q2
$25M Buy
317,650
+2,145
+0.7% +$161K 0.45% 74
2016
Q1
$22.7M Buy
315,505
+26,307
+9% +$1.99M 0.39% 96
2015
Q4
$24.4M Buy
289,198
+17,280
+6% +$1.43M 0.4% 90
2015
Q3
$22.8M Sell
271,918
-6,385
-2% -$539K 0.36% 112
2015
Q2
$23.2M Sell
278,303
-6,468
-2% -$493K 0.31% 116
2015
Q1
$20.7M Sell
284,771
-909
-0.3% -$64.7K 0.25% 121
2014
Q4
$19.7M Sell
285,680
-128,057
-31% -$8.64M 0.23% 124
2014
Q3
$26.8M Sell
413,737
-6,072
-1% -$384K 0.31% 104
2014
Q2
$26.1M Buy
419,809
+1,192
+0.3% +$71.1K 0.28% 114
2014
Q1
$24.6M Buy
418,617
+2,163
+0.5% +$121K 0.26% 118
2013
Q4
$21.2M Sell
416,454
-61,905
-13% -$3.1M 0.23% 126
2013
Q3
$24.1M Sell
478,359
-50,623
-10% -$2.65M 0.28% 106
2013
Q2
$26M Buy
+528,982
New +$28.8M 0.34% 97

Other funds holding LLY

Kornitzer Capital Management's LLY Position: Q1 2026 in Review

Kornitzer Capital Management reduced its Eli Lilly (LLY) stake by 2.4% in Q1 2026, selling an estimated $2.71M and leaving 108,463 shares worth $99.8M. The position accounts for 2.15% of the portfolio, ranked #5.

Kornitzer Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kornitzer Capital Management held 108,463 shares of Eli Lilly worth $99.8M as of Q1 2026.
  • Kornitzer Capital Management sold 2,677 Eli Lilly shares in Q1 2026, an estimated $2.71M.
  • Eli Lilly made up 2.15% of Kornitzer Capital Management's portfolio in Q1 2026, its #5 holding.
  • Kornitzer Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Kornitzer Capital Management's Eli Lilly position peaked at $120M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kornitzer Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.